Vaccine companies develop biological products that train the immune system to recognise and respond to infectious agents, cancer-associated targets and other disease-related antigens. Their work spans human health, veterinary medicine and preparedness for emerging pathogens.
This category includes companies working on:
Browse 69 UK vaccine companies below.
mRNA vaccine manufacturer and R&D partner
Moderna is a company developing and manufacturing mRNA-based medicines and vaccines across infectious disease, oncology and rare disease. Its UK Innovation and Technology Centre, opened at Harwell in September 2025, is the first facility in the UK capable of onshore mRNA vaccine manufacturing, with capacity for up to…
Computationally designed broadly protective vaccines against pandemic viruses
DIOSynVax is a clinical-stage biotechnology company developing broadly protective vaccines using a computational antigen design platform. The company's technology applies protein structure modelling and immune optimisation to engineer synthetic vaccine antigen payloads targeting conserved regions of viruses, enabling…
Herpesvirus-vectored vaccines for livestock and companion animals
The Vaccine Group develops recombinant herpesvirus-vectored vaccines against infectious diseases affecting livestock and companion animals. Its modular platform is designed to generate durable immune responses in young animals, including those carrying maternally derived antibodies. Development programmes include…
Non-profit partnership developing livestock health products for low-income markets
GALVmed is a non-profit public-private partnership facilitating the development and market access of vaccines, pharmaceuticals, and diagnostics for livestock diseases affecting small-scale producers in sub-Saharan Africa and South Asia. Operating as a product development partnership, it coordinates funding, regulatory…
Precision oncology drugs and vaccines for cold tumours
IngenOx Therapeutics Limited is a clinical-stage biopharmaceutical company developing precision oncology drugs and cancer vaccines for difficult-to-treat tumours. The company serves oncology patients and clinical development partners through a pipeline spanning small molecule immunomodulators, PRMT5 inhibition and…
Thermostable vaccine platform eliminating cold chain dependency
Stablepharma is a clinical-stage biotechnology company developing fridge-free vaccines and biologicals using. Its technology reformulates temperature-sensitive products into thermostable formulations that remain potent without refrigeration. The technology addresses cold chain failure, which the WHO estimates causes…
Immuno-oncology therapies targeting the nfP2X7 cancer receptor
Biosceptre is a UK-headquartered clinical-stage biotechnology company developing cancer therapeutics based on its proprietary nfP2X7 platform. The nfP2X7 receptor is a non-functional form of P2X7 expressed on cancer cells across a broad range of tumour types, enabling targeted therapeutic approaches. The pipeline…
T cell immunotherapies for infectious disease, cancer and autoimmunity
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing antigen-specific T cell immunotherapies for chronic infectious diseases, autoimmune conditions, and cancer. Its pipeline is built on four proprietary viral vector and synthetic immunotherapy platforms and includes clinical candidates…
Off-the-shelf cancer immunotherapies targeting solid tumours
Scancell is a clinical-stage biotech developing active immunotherapies and antibody-based therapeutics for cancer. Its pipeline spans DNA cancer vaccines, peptide immunotherapies and tumour-specific monoclonal antibodies targeting glycans expressed on cancer cells. Lead programmes iSCIB1+ and Modi-1 are in Phase 2…
Separation, purification, and sample preparation tools for life science workflows
Biotage GB is the UK subsidiary of Biotage AB, a Swedish life science tools group with manufacturing roots in Wales dating to 1969. Operating from facilities in Ystrad Mynach and Cardiff, the company designs and manufactures flash purification instruments and columns, solid phase extraction cartridges, and automated…
Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer
SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's SporeVax platform uses bacterial spores as a vaccine delivery agent, and its SPOR-COV nasal spray, developed with a commercial partner, aims…
Cell-based platform for next-generation mRNA medicines
Sensible Biotechnologies is a biotechnology company developing a cell-based platform for the design, optimisation, and manufacturing of high-quality mRNA. Using engineered living cells and precision fermentation, the platform produces low-immunogenicity mRNA at scale, addressing fundamental limitations of conventional…
Phase 1 clinical research and bioanalytical services for drug development
Celerion is a contract research organisation specialising in early-stage clinical research for pharmaceutical and biotechnology clients. Operating from a dedicated Phase 1 clinic in Belfast, the company conducts first-in-human studies, bioequivalence and bioavailability trials, cardiac safety studies, and ADME…
AAV gene therapy company targeting inherited and common retinal diseases
Beacon Therapeutics is a clinical-stage UK biopharma company developing adeno-associated virus (AAV) gene therapies for retinal diseases causing blindness. Its lead programme, laru-zova (AGTC-501), is in Phase II/III clinical trials for X-linked retinitis pigmentosa. The pipeline also includes preclinical programmes…
Broad-spectrum intranasal antivirals targeting respiratory viral infections
Pneumagen is a Scottish clinical-stage biotechnology company developing broad-spectrum intranasal antiviral therapies. Pneumagen's platform generates multivalent carbohydrate binding molecules (mCBMs) that block viral entry by binding to sialic acid residues on host epithelial cells. In 2026, Pneumagen reorganized…
Novel mRNA technology platform for safer, faster vaccines
CamMed Therapeutics (Cambridge Medixine Ltd) is a preclinical biotechnology company developing a novel mRNA technology platform for vaccines and therapeutics. Inspired by natural biological phenomena, its engineered RNA molecules are designed to deliver safer, easier and faster medicines to the clinic while reducing…
High-performance specialty ingredients for pharma, biotech and agriculture
Croda is a speciality chemicals company developing and manufacturing high-performance ingredients for pharmaceutical, biotechnology, and agricultural markets. Its life sciences portfolio encompasses lipid nanoparticle delivery systems, high-purity pharmaceutical excipients, vaccine adjuvant components, and crop…
CRO specialising in human challenge trials
hVIVO is a specialist contract research organisation providing human challenge trial services for infectious and respiratory disease. The company conducts controlled human infection studies across more than 14 validated viral challenge models, supporting the development of vaccines and antivirals for clients including…
UK and Ireland distributor of specialist analytical and life science instruments
Analytik is a scientific instrumentation distributor supplying specialist equipment to research, academic, and industrial organisations across the UK and Ireland. The company holds exclusive or preferred distribution agreements with a portfolio of international technology manufacturers, covering particle…
Preclinical vaccines targeting antimicrobial-resistant bacterial infections
VacTimmune is a biotechnology company developing preventative vaccines against bacterial pathogens associated with antimicrobial resistance. Its preclinical pipeline includes candidates targeting Pseudomonas aeruginosa, Klebsiella pneumoniae and other clinically important bacteria, with an emphasis on infections…